| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |